E Donnelly
Overview
Explore the profile of E Donnelly including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
451
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammonds J, Price R, Donnelly E, Pickens D
Med Phys
. 2017 May;
39(6Part5):3642.
PMID: 28517623
Purpose: A laboratory-based phase-contrast radiography/tomosynthesis imaging system previously (Med. Phys. Vol. 38, 2353 May 2011) for improved detection of low-contrast soft-tissue masses was used to evaluate the sensitivity for detecting...
2.
Selaru P, Tang Y, Huang B, Polli A, Wilner K, Donnelly E, et al.
Clin Transl Sci
. 2016 Feb;
9(2):63-73.
PMID: 26841346
No abstract available.
3.
Bacon S, Kyithar M, Rizvi S, Donnelly E, McCarthy A, Burke M, et al.
Diabet Med
. 2015 Oct;
33(7):976-84.
PMID: 26479152
Aims: HNF1A gene mutations are the most common cause of maturity-onset diabetes of the young (MODY) in the UK. Persons with HNF1A-MODY display sensitivity to sulphonylurea therapy; however, the long-term...
4.
Deeley M, Chen A, Datteri R, Noble J, Cmelak A, Donnelly E, et al.
Phys Med Biol
. 2013 May;
58(12):4071-97.
PMID: 23685866
Image segmentation has become a vital and often rate-limiting step in modern radiotherapy treatment planning. In recent years, the pace and scope of algorithm development, and even introduction into the...
5.
El Naqa I, Grigsby P, Apte A, Kidd E, Donnelly E, Khullar D, et al.
Pattern Recognit
. 2010 Feb;
42(6):1162-1171.
PMID: 20161266
Accumulating evidence suggests that characteristics of pre-treatment FDG-PET could be used as prognostic factors to predict outcomes in different cancer sites. Current risk analyses are limited to visual assessment or...
6.
Hinkle R, Donnelly E, Cody D, Bauer M, Sheldon R, Isfort R
J Muscle Res Cell Motil
. 2005 Feb;
25(7):539-47.
PMID: 15711884
Of the two corticotropin releasing factor receptors known, corticotrophin releasing factor 2 receptor (CRF2R) is expressed in skeletal muscle. The function of this receptor in skeletal muscle is at present...
7.
Robles C, Furst A, Sriratana P, Lai S, Chua L, Donnelly E, et al.
Oncol Rep
. 2003 Jun;
10(4):885-9.
PMID: 12792740
A phase II trial of vinorelbine and low dose prednisone in hormone-refractory metastatic prostate cancer was conducted in order to investigate its safety, efficacy and impact on quality of life....
8.
Geng L, Donnelly E, McMahon G, Lin P, Oshinka H, Hallahan D
Cancer Res
. 2001 Apr;
61(6):2413-9.
PMID: 11289107
Certain refractory neoplasms, such as glioblastoma multiforme (GBM) and melanoma, demonstrate a resistant tumor phenotype in vivo. We observed that these refractory tumor models (GBM and melanoma) contain blood vessels...
9.
Bennett S, Cordes D, Westmoreland G, Castro R, Donnelly E
Nurs Res
. 2000 Jul;
49(3):139-45.
PMID: 10882318
Background: The troublesome symptoms experienced by patients with chronic heart failure are associated with diminished quality of life, frequent hospitalizations, and mortality. Objectives: To describe the symptoms experienced by patients...
10.
Savaraj N, Wu C, Xu R, Lampidis T, Lai S, Donnelly E, et al.
Am J Clin Oncol
. 1997 Aug;
20(4):398-403.
PMID: 9256898
The development of drug resistance can contribute to treatment failure in small-cell lung cancer (SCLC). In this report, we investigate p-glycoprotein-mediated multidrug resistance (MDR) in these patients. Tumor tissue was...